nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—Candesartan—ABCB1—peripheral nervous system neoplasm	0.00135	0.608	CrCbGaD
Valsartan—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.0011	CcSEcCtD
Valsartan—Rash—Topotecan—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Valsartan—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Valsartan—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Valsartan—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Valsartan—Cough—Etoposide—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Valsartan—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Valsartan—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Valsartan—Headache—Topotecan—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Valsartan—Rash—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Valsartan—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Valsartan—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Valsartan—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Valsartan—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Valsartan—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Valsartan—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Valsartan—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Valsartan—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Valsartan—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Valsartan—Headache—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Valsartan—Constipation—Vincristine—peripheral nervous system neoplasm	0.00107	0.00108	CcSEcCtD
Valsartan—Rash—Melphalan—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Valsartan—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Valsartan—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Valsartan—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Valsartan—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Valsartan—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Valsartan—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00105	0.00106	CcSEcCtD
Valsartan—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Valsartan—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Valsartan—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Valsartan—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Valsartan—Nausea—Topotecan—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Valsartan—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Valsartan—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00103	CcSEcCtD
Valsartan—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Valsartan—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Valsartan—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Valsartan—Infection—Etoposide—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Valsartan—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Valsartan—Nausea—Melphalan—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Valsartan—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Valsartan—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000997	0.000999	CcSEcCtD
Valsartan—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000996	0.000998	CcSEcCtD
Valsartan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000992	0.000994	CcSEcCtD
Valsartan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000989	0.000992	CcSEcCtD
Valsartan—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000988	0.00099	CcSEcCtD
Valsartan—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00098	0.000982	CcSEcCtD
Valsartan—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00098	0.000982	CcSEcCtD
Valsartan—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000969	0.000971	CcSEcCtD
Valsartan—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000965	0.000967	CcSEcCtD
Valsartan—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000964	0.000966	CcSEcCtD
Valsartan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000961	0.000963	CcSEcCtD
Valsartan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00096	0.000962	CcSEcCtD
Valsartan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000958	0.00096	CcSEcCtD
Valsartan—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00095	0.000952	CcSEcCtD
Valsartan—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000946	0.000948	CcSEcCtD
Valsartan—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000937	0.000939	CcSEcCtD
Valsartan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000935	0.000937	CcSEcCtD
Valsartan—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000931	0.000934	CcSEcCtD
Valsartan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000925	0.000927	CcSEcCtD
Valsartan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000922	0.000924	CcSEcCtD
Valsartan—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000915	0.000917	CcSEcCtD
Valsartan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000913	0.000915	CcSEcCtD
Valsartan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000906	0.000908	CcSEcCtD
Valsartan—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000904	0.000906	CcSEcCtD
Valsartan—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000901	0.000903	CcSEcCtD
Valsartan—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000894	0.000896	CcSEcCtD
Valsartan—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000894	0.000896	CcSEcCtD
Valsartan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000893	0.000895	CcSEcCtD
Valsartan—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000892	0.000894	CcSEcCtD
Valsartan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000891	0.000893	CcSEcCtD
Valsartan—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000886	0.000888	CcSEcCtD
Valsartan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000884	0.000886	CcSEcCtD
Valsartan—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000878	0.00088	CcSEcCtD
Valsartan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000878	0.00088	CcSEcCtD
Valsartan—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000877	0.000879	CcSEcCtD
Valsartan—Constipation—Etoposide—peripheral nervous system neoplasm	0.000869	0.000871	CcSEcCtD
Valsartan—Losartan—ABCB1—peripheral nervous system neoplasm	0.000867	0.392	CrCbGaD
Valsartan—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000867	0.000869	CcSEcCtD
Valsartan—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000862	0.000864	CcSEcCtD
Valsartan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000861	0.000863	CcSEcCtD
Valsartan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000859	0.000861	CcSEcCtD
Valsartan—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000846	0.000848	CcSEcCtD
Valsartan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000843	0.000845	CcSEcCtD
Valsartan—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000838	0.00084	CcSEcCtD
Valsartan—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000834	0.000836	CcSEcCtD
Valsartan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000831	0.000833	CcSEcCtD
Valsartan—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00083	0.000832	CcSEcCtD
Valsartan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000828	0.00083	CcSEcCtD
Valsartan—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000827	0.000829	CcSEcCtD
Valsartan—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000827	0.000829	CcSEcCtD
Valsartan—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.000823	CcSEcCtD
Valsartan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.000822	CcSEcCtD
Valsartan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000818	0.00082	CcSEcCtD
Valsartan—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000816	0.000818	CcSEcCtD
Valsartan—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000813	0.000815	CcSEcCtD
Valsartan—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000808	0.00081	CcSEcCtD
Valsartan—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000806	0.000808	CcSEcCtD
Valsartan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000804	0.000806	CcSEcCtD
Valsartan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000804	0.000806	CcSEcCtD
Valsartan—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000802	0.000804	CcSEcCtD
Valsartan—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000802	0.000804	CcSEcCtD
Valsartan—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000798	0.0008	CcSEcCtD
Valsartan—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000796	0.000798	CcSEcCtD
Valsartan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000796	0.000798	CcSEcCtD
Valsartan—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000792	0.000794	CcSEcCtD
Valsartan—Rash—Vincristine—peripheral nervous system neoplasm	0.000791	0.000793	CcSEcCtD
Valsartan—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000791	0.000792	CcSEcCtD
Valsartan—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000788	0.00079	CcSEcCtD
Valsartan—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000786	0.000788	CcSEcCtD
Valsartan—Headache—Vincristine—peripheral nervous system neoplasm	0.000786	0.000788	CcSEcCtD
Valsartan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.000782	CcSEcCtD
Valsartan—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000776	0.000777	CcSEcCtD
Valsartan—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000774	0.000775	CcSEcCtD
Valsartan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000759	0.000761	CcSEcCtD
Valsartan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000749	0.000751	CcSEcCtD
Valsartan—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.000748	CcSEcCtD
Valsartan—Nausea—Vincristine—peripheral nervous system neoplasm	0.000746	0.000747	CcSEcCtD
Valsartan—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000745	0.000746	CcSEcCtD
Valsartan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000744	0.000746	CcSEcCtD
Valsartan—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000742	0.000744	CcSEcCtD
Valsartan—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000742	0.000744	CcSEcCtD
Valsartan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000737	0.000738	CcSEcCtD
Valsartan—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000733	0.000735	CcSEcCtD
Valsartan—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00073	0.000731	CcSEcCtD
Valsartan—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000729	0.000731	CcSEcCtD
Valsartan—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000728	0.000729	CcSEcCtD
Valsartan—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.000729	CcSEcCtD
Valsartan—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000725	0.000726	CcSEcCtD
Valsartan—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000723	0.000725	CcSEcCtD
Valsartan—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000719	0.000721	CcSEcCtD
Valsartan—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000709	0.00071	CcSEcCtD
Valsartan—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000706	0.000707	CcSEcCtD
Valsartan—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000703	0.000704	CcSEcCtD
Valsartan—Rash—Cisplatin—peripheral nervous system neoplasm	0.0007	0.000701	CcSEcCtD
Valsartan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000699	0.000701	CcSEcCtD
Valsartan—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000698	0.0007	CcSEcCtD
Valsartan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000696	0.000697	CcSEcCtD
Valsartan—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000689	0.00069	CcSEcCtD
Valsartan—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000688	0.00069	CcSEcCtD
Valsartan—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000684	0.000685	CcSEcCtD
Valsartan—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000676	0.000677	CcSEcCtD
Valsartan—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000673	0.000675	CcSEcCtD
Valsartan—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000672	0.000674	CcSEcCtD
Valsartan—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000671	0.000673	CcSEcCtD
Valsartan—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00067	0.000672	CcSEcCtD
Valsartan—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.00067	CcSEcCtD
Valsartan—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000659	0.000661	CcSEcCtD
Valsartan—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000658	0.00066	CcSEcCtD
Valsartan—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000656	0.000657	CcSEcCtD
Valsartan—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00065	0.000652	CcSEcCtD
Valsartan—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000646	0.000648	CcSEcCtD
Valsartan—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000646	0.000648	CcSEcCtD
Valsartan—Rash—Etoposide—peripheral nervous system neoplasm	0.000641	0.000643	CcSEcCtD
Valsartan—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00064	0.000642	CcSEcCtD
Valsartan—Headache—Etoposide—peripheral nervous system neoplasm	0.000637	0.000638	CcSEcCtD
Valsartan—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000637	0.000638	CcSEcCtD
Valsartan—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000633	0.000634	CcSEcCtD
Valsartan—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000627	0.000629	CcSEcCtD
Valsartan—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000626	0.000628	CcSEcCtD
Valsartan—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000626	CcSEcCtD
Valsartan—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000621	0.000623	CcSEcCtD
Valsartan—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000617	0.000619	CcSEcCtD
Valsartan—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000614	0.000615	CcSEcCtD
Valsartan—Cough—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000611	CcSEcCtD
Valsartan—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000609	0.00061	CcSEcCtD
Valsartan—Nausea—Etoposide—peripheral nervous system neoplasm	0.000604	0.000605	CcSEcCtD
Valsartan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000596	CcSEcCtD
Valsartan—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000596	CcSEcCtD
Valsartan—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000596	CcSEcCtD
Valsartan—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000592	0.000594	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00059	0.000592	CcSEcCtD
Valsartan—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000581	0.000583	CcSEcCtD
Valsartan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.000582	CcSEcCtD
Valsartan—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000579	0.000581	CcSEcCtD
Valsartan—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000572	CcSEcCtD
Valsartan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00057	0.000571	CcSEcCtD
Valsartan—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00057	0.000571	CcSEcCtD
Valsartan—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000569	CcSEcCtD
Valsartan—Infection—Epirubicin—peripheral nervous system neoplasm	0.000566	0.000567	CcSEcCtD
Valsartan—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.000565	CcSEcCtD
Valsartan—Shock—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000562	CcSEcCtD
Valsartan—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000559	0.00056	CcSEcCtD
Valsartan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000559	CcSEcCtD
Valsartan—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000555	CcSEcCtD
Valsartan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.000551	CcSEcCtD
Valsartan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.000551	CcSEcCtD
Valsartan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.000551	CcSEcCtD
Valsartan—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.000549	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000548	CcSEcCtD
Valsartan—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000543	0.000544	CcSEcCtD
Valsartan—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000539	CcSEcCtD
Valsartan—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000533	0.000534	CcSEcCtD
Valsartan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000529	CcSEcCtD
Valsartan—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000529	CcSEcCtD
Valsartan—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000525	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000519	0.00052	CcSEcCtD
Valsartan—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.00052	CcSEcCtD
Valsartan—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.000518	CcSEcCtD
Valsartan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000517	CcSEcCtD
Valsartan—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000517	CcSEcCtD
Valsartan—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000513	CcSEcCtD
Valsartan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000512	0.000513	CcSEcCtD
Valsartan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000509	CcSEcCtD
Valsartan—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000508	CcSEcCtD
Valsartan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.000504	CcSEcCtD
Valsartan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000503	CcSEcCtD
Valsartan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000497	CcSEcCtD
Valsartan—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000494	CcSEcCtD
Valsartan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000493	CcSEcCtD
Valsartan—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000491	0.000492	CcSEcCtD
Valsartan—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000487	0.000488	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000482	CcSEcCtD
Valsartan—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000478	CcSEcCtD
Valsartan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000475	CcSEcCtD
Valsartan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000471	CcSEcCtD
Valsartan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.00047	CcSEcCtD
Valsartan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000467	CcSEcCtD
Valsartan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000465	CcSEcCtD
Valsartan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000459	CcSEcCtD
Valsartan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000456	CcSEcCtD
Valsartan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000456	CcSEcCtD
Valsartan—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000454	CcSEcCtD
Valsartan—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.000452	CcSEcCtD
Valsartan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000452	CcSEcCtD
Valsartan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000432	CcSEcCtD
Valsartan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000421	CcSEcCtD
Valsartan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.00042	CcSEcCtD
Valsartan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000418	CcSEcCtD
Valsartan—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000409	0.00041	CcSEcCtD
Valsartan—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000404	CcSEcCtD
Valsartan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000391	CcSEcCtD
Valsartan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Valsartan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000379	CcSEcCtD
Valsartan—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000378	CcSEcCtD
Valsartan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000374	CcSEcCtD
Valsartan—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000363	CcSEcCtD
Valsartan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000362	CcSEcCtD
Valsartan—Rash—Epirubicin—peripheral nervous system neoplasm	0.000359	0.00036	CcSEcCtD
Valsartan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000359	0.00036	CcSEcCtD
Valsartan—Headache—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000358	CcSEcCtD
Valsartan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.00035	CcSEcCtD
Valsartan—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Valsartan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000336	CcSEcCtD
Valsartan—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Valsartan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000333	CcSEcCtD
Valsartan—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000331	CcSEcCtD
Valsartan—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000314	CcSEcCtD
